Universal-Beteiligungs- und Servicegesellschaft
INDV icon

Universal-Beteiligungs- und Servicegesellschaft’s Indivior Pharmaceuticals INDV Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.06M Buy
172,124
+35,867
+26% +$1.3M 0.01% 794
2026
Q1 		$4.15M Buy
+136,257
New +$4.5M 0.01% 955

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's INDV Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Indivior Pharmaceuticals (INDV) stake by 26% in Q2 2026, buying an estimated $1.3M and bringing the position to 172,124 shares worth $7.06M. The position accounts for 0.01% of the portfolio, ranked #794.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in INDV in Q1 2026 and has held it in 2 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 172,124 shares of Indivior Pharmaceuticals worth $7.06M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 35,867 Indivior Pharmaceuticals shares in Q2 2026, an estimated $1.3M.
  • Indivior Pharmaceuticals made up 0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #794 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Indivior Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.